Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B.

Kitamura Y, Scavarda N, Wells SA Jr, Jackson CE, Goodfellow PJ.

Hum Mol Genet. 1995 Oct;4(10):1987-8. No abstract available.

PMID:
8595427
2.

Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q.

Kwon JM, Elliott JL, Yee WC, Ivanovich J, Scavarda NJ, Moolsintong PJ, Goodfellow PJ.

Am J Hum Genet. 1995 Oct;57(4):853-8.

3.

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA Jr, Goodfellow PJ, Donis-Keller H.

Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1579-83.

4.

Expression and function of TRK-B and BDNF in human neuroblastomas.

Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM.

Mol Cell Biol. 1994 Jan;14(1):759-67.

5.

Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.

Azar CG, Scavarda NJ, Nakagawara A, Brodeur GM.

Prog Clin Biol Res. 1994;385:169-75.

PMID:
7972209
6.

Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma.

Nakagawara A, Arima-Nakagawara M, Azar CG, Scavarda NJ, Brodeur GM.

Prog Clin Biol Res. 1994;385:155-61. No abstract available.

PMID:
7972207
7.

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.

Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.

N Engl J Med. 1993 Mar 25;328(12):847-54.

8.

Neuroblastoma. Effect of genetic factors on prognosis and treatment.

Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N, et al.

Cancer. 1992 Sep 15;70(6 Suppl):1685-94.

PMID:
1325279
9.

Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.

Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.

Cancer Res. 1992 Mar 1;52(5):1364-8.

10.

Multiple defects of the nerve growth factor receptor in human neuroblastomas.

Azar C, Scavarda NJ, Reynolds CP, Brodeur GM.

Prog Clin Biol Res. 1991;366:219-26.

PMID:
2068140
11.

Multiple defects of the nerve growth factor receptor in human neuroblastomas.

Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM.

Cell Growth Differ. 1990 Sep;1(9):421-8.

12.

Nucleotide sequence of the putative sodium channel gene from Drosophila: the four homologous domains.

Salkoff L, Butler A, Scavarda N, Wei A.

Nucleic Acids Res. 1987 Oct 26;15(20):8569-72. No abstract available.

13.

Genomic organization and deduced amino acid sequence of a putative sodium channel gene in Drosophila.

Salkoff L, Butler A, Wei A, Scavarda N, Giffen K, Ifune C, Goodman R, Mandel G.

Science. 1987 Aug 14;237(4816):744-9.

PMID:
2441469
14.

Interspecific DNA transformation in Drosophila.

Scavarda NJ, Hartl DL.

Proc Natl Acad Sci U S A. 1984 Dec;81(23):7515-9.

15.

Drosophila locus with gene-dosage effects on rhodopsin.

Scavarda NJ, O'tousa J, Pak WL.

Proc Natl Acad Sci U S A. 1983 Jul;80(14):4441-5.

16.

Drosophila mutants with reduced rhodopsin content.

Stephenson RS, O'Tousa J, Scavarda NJ, Randall LL, Pak WL.

Symp Soc Exp Biol. 1983;36:477-501. Review. No abstract available.

PMID:
6399788
17.

Supplemental Content

Loading ...
Support Center